Endocrine Society Development SRL
Endocrine Society Development reported total assets of 862,328 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Apr 2026).
The score of Endocrine Society Development shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +24 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Endocrine Society Development's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 151,962 € | ||||
| Equity | 644,152 € | ||||
| Cash | 154,244 € | ||||
| EBITDA | 239,958 € | ||||
| Total assets | 862,328 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Apr 2026
- Year ended 30 Sep 2024filed on 08 May 2025
- Year ended 30 Sep 2023filed on 23 Apr 2024
- Year ended 30 Sep 2022filed on 05 Apr 2023
- Year ended 30 Sep 2021filed on 26 Apr 2022
Endocrine Society Development's financial analysis
Management and control of Endocrine Society Development
Endocrine Society Development's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0882.241.922
- VAT number
- BE0882241922
- Peppol
- Registered · 0208:0882241922 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Jul 2006
- Registered office
- 6660 Houffalize
- Latest accounts
- 2025 · filed on 30 Apr 2026
Endocrine Society Development (SRL) has been based in Houffalize since 2006, active in: —. For 2025, it reports a net profit of 151,962 € and equity of 644,152 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Endocrine Society Development
Companies in the same business, of comparable size and area, outside its group.
- Cabinet Médical Docteur BROUILLARD Luc General medical practice activities Beloeil · balance sheet 862,337 €
- A. Honoré et Fils Ixelles · balance sheet €1.73m
- AYCO Restaurant activities Brussels · balance sheet 862,231 €
- Dr. KH Medical specialists activities Hasselt · balance sheet 862,435 €
- Dr. Greet Lemmens Antwerp · balance sheet 862,187 €
- NIMA Rental and operating of own or leased real estate Lochristi · balance sheet 862,473 €
- Pierre Félix SENECAUT Rental and operating of own or leased real estate Jurbise · balance sheet 862,143 €
- RdH Immo Buying and selling of own real estate Braine-le-Château · balance sheet 862,121 €
Frequently asked questions about Endocrine Society Development
What is the revenue of Endocrine Society Development?
Endocrine Society Development files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Endocrine Society Development?
In Belgium, the VAT number is the company number prefixed with BE: BE0882241922 for Endocrine Society Development, if the company is VAT-registered. Its company number (CBE) is 0882.241.922.
Where is the registered office of Endocrine Society Development?
According to the CBE register, the registered office of Endocrine Society Development is in 6660 Houffalize.
What is the equity of Endocrine Society Development?
At the close of the 2025 financial year, the equity of Endocrine Society Development amounts to 644,152 €, a solvency of 74.7% of total assets.
Who manages Endocrine Society Development?
The register lists 1 active mandates at Endocrine Society Development. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Endocrine Society Development
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →